Omya International’s acquisition of industrial site in Egerkingen from Spirig Pharma

Paolo Bossi

Omya International will be moving its research and development activities to Egerkingen after the acquisition of the Galderma-Spirig site. The buildings in Egerkingen have a modern…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Paolo Bossi

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here